お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はmRNA生酵素市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはmRNA生酵素の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のmRNA生酵素市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはmRNA生酵素のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にmRNA生酵素市場を分類しています。本研究に含まれる主な企業は：Thermo Fisher、NEB、TriLink Bio Technologies、Merck、Aldevron、Qiagen N.V.、Promega、Roche CustomBiotech、Takara Bio Inc、Novoprotein、Vazyme、Hongene Biotech Corporatio、Yeasen Biotechnology (Shanghai)、Kactus Biosystems

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Capping Enzyme
    2'-O-Methyltransferase
    Inorganic Pyrophosphatase
    Poly (A) Polymerase
    Rnase Inhibitor
    RNA Polymerase
    Restriction Enzyme
    Dnase I
    Others

用途別の市場セグメント：
    Biopharmaceutical Companies
    Academic and Research Institutes

本レポートの詳細内容
世界のmRNA生酵素市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、mRNA生酵素タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のmRNA生酵素収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のmRNA生酵素市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、mRNA生酵素市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

mRNA生酵素のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：mRNA生酵素のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：mRNA生酵素の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章mRNA生酵素企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：mRNA生酵素の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：mRNA生酵素の主要企業の概要を提供し、製品の説明と仕様、mRNA生酵素の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

mRNA raw enzyme is the key raw material in the production of mRNA vaccine and drugs. The research, development and production of mRNA drugs involve restriction endonuclease, RNA polymerase, capping enzyme, Poly (A) polymerase and other enzyme materials. In this report, mRNA Raw Enzyme includes Restriction Enzyme, RNA Polymerase, Capping Enzyme, Inorganic Pyrophosphatase, RNase Inhibitor, 2"-O-Methyltransferase, Poly(A) Polymerase and DNase I.
The global mRNA Raw Enzyme market is projected to grow from US$ 1591 million in 2024 to US$ 1731 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.4% during the forecast period.
Global key players of mRNA Raw Enzyme include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, etc. The top five players hold a share about 62%. North America is the largest market, and has a share about 41%, followed by Europe and Asia-Pacific with share 34% and 21%, separately. In terms of product type, Capping Enzyme is the largest segment, accounting for a share of 26%. In terms of application, Biopharmaceutical Companies is the largest field with a share about 63 percent.
Report Includes
This report presents an overview of global market for mRNA Raw Enzyme market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of mRNA Raw Enzyme, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Raw Enzyme, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Raw Enzyme revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global mRNA Raw Enzyme market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for mRNA Raw Enzyme revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc, Novoprotein, etc.
Market Segmentation
By Company
    Thermo Fisher
    NEB
    TriLink Bio Technologies
    Merck
    Aldevron
    Qiagen N.V.
    Promega
    Roche CustomBiotech
    Takara Bio Inc
    Novoprotein
    Vazyme
    Hongene Biotech Corporatio
    Yeasen Biotechnology (Shanghai)
    Kactus Biosystems

Segment by Type
    Capping Enzyme
    2'-O-Methyltransferase
    Inorganic Pyrophosphatase
    Poly (A) Polymerase
    Rnase Inhibitor
    RNA Polymerase
    Restriction Enzyme
    Dnase I
    Others

Segment by Application
    Biopharmaceutical Companies
    Academic and Research Institutes

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Raw Enzyme in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Raw Enzyme companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Raw Enzyme revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global mRNA Raw Enzyme Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Capping Enzyme
 Table 3. Key Players of 2'-O-Methyltransferase
 Table 4. Key Players of Inorganic Pyrophosphatase
 Table 5. Key Players of Poly (A) Polymerase
 Table 6. Key Players of Rnase Inhibitor
 Table 7. Key Players of RNA Polymerase
 Table 8. Key Players of Restriction Enzyme
 Table 9. Global mRNA Raw Enzyme Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 10. Global mRNA Raw Enzyme Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 11. Global mRNA Raw Enzyme Market Size by Region (2019-2024) & (US$ Million)
 Table 12. Global mRNA Raw Enzyme Market Share by Region (2019-2024)
 Table 13. Global mRNA Raw Enzyme Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 14. Global mRNA Raw Enzyme Market Share by Region (2025-2030)
 Table 15. mRNA Raw Enzyme Market Trends
 Table 16. mRNA Raw Enzyme Market Drivers
 Table 17. mRNA Raw Enzyme Market Challenges
 Table 18. mRNA Raw Enzyme Market Restraints
 Table 19. Global mRNA Raw Enzyme Revenue by Players (2019-2024) & (US$ Million)
 Table 20. Global mRNA Raw Enzyme Market Share by Players (2019-2024)
 Table 21. Global Top mRNA Raw Enzyme Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Raw Enzyme as of 2023)
 Table 22. Global mRNA Raw Enzyme Industry Ranking 2022 VS 2023
 Table 23. Global 5 Largest Players Market Share by mRNA Raw Enzyme Revenue (CR5 and HHI) & (2019-2024)
 Table 24. Global Key Players of mRNA Raw Enzyme, Headquarters and Area Served
 Table 25. Global Key Players of mRNA Raw Enzyme, Product and Application
 Table 26. Global Key Players of mRNA Raw Enzyme, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global mRNA Raw Enzyme Market Size by Type (2019-2024) & (US$ Million)
 Table 29. Global mRNA Raw Enzyme Revenue Market Share by Type (2019-2024)
 Table 30. Global mRNA Raw Enzyme Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 31. Global mRNA Raw Enzyme Revenue Market Share by Type (2025-2030)
 Table 32. Global mRNA Raw Enzyme Market Size by Application (2019-2024) & (US$ Million)
 Table 33. Global mRNA Raw Enzyme Revenue Market Share by Application (2019-2024)
 Table 34. Global mRNA Raw Enzyme Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 35. Global mRNA Raw Enzyme Revenue Market Share by Application (2025-2030)
 Table 36. North America mRNA Raw Enzyme Market Size by Type (2019-2024) & (US$ Million)
 Table 37. North America mRNA Raw Enzyme Market Size by Type (2025-2030) & (US$ Million)
 Table 38. North America mRNA Raw Enzyme Market Size by Application (2019-2024) & (US$ Million)
 Table 39. North America mRNA Raw Enzyme Market Size by Application (2025-2030) & (US$ Million)
 Table 40. North America mRNA Raw Enzyme Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. North America mRNA Raw Enzyme Market Size by Country (2019-2024) & (US$ Million)
 Table 42. North America mRNA Raw Enzyme Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Europe mRNA Raw Enzyme Market Size by Type (2019-2024) & (US$ Million)
 Table 44. Europe mRNA Raw Enzyme Market Size by Type (2025-2030) & (US$ Million)
 Table 45. Europe mRNA Raw Enzyme Market Size by Application (2019-2024) & (US$ Million)
 Table 46. Europe mRNA Raw Enzyme Market Size by Application (2025-2030) & (US$ Million)
 Table 47. Europe mRNA Raw Enzyme Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 48. Europe mRNA Raw Enzyme Market Size by Country (2019-2024) & (US$ Million)
 Table 49. Europe mRNA Raw Enzyme Market Size by Country (2025-2030) & (US$ Million)
 Table 50. China mRNA Raw Enzyme Market Size by Type (2019-2024) & (US$ Million)
 Table 51. China mRNA Raw Enzyme Market Size by Type (2025-2030) & (US$ Million)
 Table 52. China mRNA Raw Enzyme Market Size by Application (2019-2024) & (US$ Million)
 Table 53. China mRNA Raw Enzyme Market Size by Application (2025-2030) & (US$ Million)
 Table 54. Asia mRNA Raw Enzyme Market Size by Type (2019-2024) & (US$ Million)
 Table 55. Asia mRNA Raw Enzyme Market Size by Type (2025-2030) & (US$ Million)
 Table 56. Asia mRNA Raw Enzyme Market Size by Application (2019-2024) & (US$ Million)
 Table 57. Asia mRNA Raw Enzyme Market Size by Application (2025-2030) & (US$ Million)
 Table 58. Asia mRNA Raw Enzyme Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 59. Asia mRNA Raw Enzyme Market Size by Region (2019-2024) & (US$ Million)
 Table 60. Asia mRNA Raw Enzyme Market Size by Region (2025-2030) & (US$ Million)
 Table 61. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size by Type (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size by Type (2025-2030) & (US$ Million)
 Table 63. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size by Application (2019-2024) & (US$ Million)
 Table 64. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size by Application (2025-2030) & (US$ Million)
 Table 65. Middle East, Africa, and Latin America mRNA Raw Enzyme Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 66. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size by Country (2019-2024) & (US$ Million)
 Table 67. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size by Country (2025-2030) & (US$ Million)
 Table 68. Thermo Fisher Company Details
 Table 69. Thermo Fisher Business Overview
 Table 70. Thermo Fisher mRNA Raw Enzyme Product
 Table 71. Thermo Fisher Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 72. Thermo Fisher Recent Development
 Table 73. NEB Company Details
 Table 74. NEB Business Overview
 Table 75. NEB mRNA Raw Enzyme Product
 Table 76. NEB Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 77. NEB Recent Development
 Table 78. TriLink Bio Technologies Company Details
 Table 79. TriLink Bio Technologies Business Overview
 Table 80. TriLink Bio Technologies mRNA Raw Enzyme Product
 Table 81. TriLink Bio Technologies Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 82. TriLink Bio Technologies Recent Development
 Table 83. Merck Company Details
 Table 84. Merck Business Overview
 Table 85. Merck mRNA Raw Enzyme Product
 Table 86. Merck Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 87. Merck Recent Development
 Table 88. Aldevron Company Details
 Table 89. Aldevron Business Overview
 Table 90. Aldevron mRNA Raw Enzyme Product
 Table 91. Aldevron Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 92. Aldevron Recent Development
 Table 93. Qiagen N.V. Company Details
 Table 94. Qiagen N.V. Business Overview
 Table 95. Qiagen N.V. mRNA Raw Enzyme Product
 Table 96. Qiagen N.V. Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 97. Qiagen N.V. Recent Development
 Table 98. Promega Company Details
 Table 99. Promega Business Overview
 Table 100. Promega mRNA Raw Enzyme Product
 Table 101. Promega Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 102. Promega Recent Development
 Table 103. Roche CustomBiotech Company Details
 Table 104. Roche CustomBiotech Business Overview
 Table 105. Roche CustomBiotech mRNA Raw Enzyme Product
 Table 106. Roche CustomBiotech Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 107. Roche CustomBiotech Recent Development
 Table 108. Takara Bio Inc Company Details
 Table 109. Takara Bio Inc Business Overview
 Table 110. Takara Bio Inc mRNA Raw Enzyme Product
 Table 111. Takara Bio Inc Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 112. Takara Bio Inc Recent Development
 Table 113. Novoprotein Company Details
 Table 114. Novoprotein Business Overview
 Table 115. Novoprotein mRNA Raw Enzyme Product
 Table 116. Novoprotein Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 117. Novoprotein Recent Development
 Table 118. Vazyme Company Details
 Table 119. Vazyme Business Overview
 Table 120. Vazyme mRNA Raw Enzyme Product
 Table 121. Vazyme Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 122. Vazyme Recent Development
 Table 123. Hongene Biotech Corporatio Company Details
 Table 124. Hongene Biotech Corporatio Business Overview
 Table 125. Hongene Biotech Corporatio mRNA Raw Enzyme Product
 Table 126. Hongene Biotech Corporatio Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 127. Hongene Biotech Corporatio Recent Development
 Table 128. Yeasen Biotechnology (Shanghai) Company Details
 Table 129. Yeasen Biotechnology (Shanghai) Business Overview
 Table 130. Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Product
 Table 131. Yeasen Biotechnology (Shanghai) Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 132. Yeasen Biotechnology (Shanghai) Recent Development
 Table 133. Kactus Biosystems Company Details
 Table 134. Kactus Biosystems Business Overview
 Table 135. Kactus Biosystems mRNA Raw Enzyme Product
 Table 136. Kactus Biosystems Revenue in mRNA Raw Enzyme Business (2019-2024) & (US$ Million)
 Table 137. Kactus Biosystems Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global mRNA Raw Enzyme Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global mRNA Raw Enzyme Market Share by Type: 2023 VS 2030
 Figure 3. Capping Enzyme Features
 Figure 4. 2'-O-Methyltransferase Features
 Figure 5. Inorganic Pyrophosphatase Features
 Figure 6. Poly (A) Polymerase Features
 Figure 7. Rnase Inhibitor Features
 Figure 8. RNA Polymerase Features
 Figure 9. Restriction Enzyme Features
 Figure 10. Global mRNA Raw Enzyme Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 11. Global mRNA Raw Enzyme Market Share by Application: 2023 VS 2030
 Figure 12. Biopharmaceutical Companies Case Studies
 Figure 13. Academic and Research Institutes Case Studies
 Figure 14. mRNA Raw Enzyme Report Years Considered
 Figure 15. Global mRNA Raw Enzyme Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 16. Global mRNA Raw Enzyme Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global mRNA Raw Enzyme Market Share by Region: 2023 VS 2030
 Figure 18. Global mRNA Raw Enzyme Market Share by Players in 2023
 Figure 19. Global Top mRNA Raw Enzyme Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Raw Enzyme as of 2023)
 Figure 20. The Top 10 and 5 Players Market Share by mRNA Raw Enzyme Revenue in 2023
 Figure 21. North America mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. North America mRNA Raw Enzyme Market Share by Type (2019-2030)
 Figure 23. North America mRNA Raw Enzyme Market Share by Application (2019-2030)
 Figure 24. North America mRNA Raw Enzyme Market Share by Country (2019-2030)
 Figure 25. United States mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Canada mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Europe mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Europe mRNA Raw Enzyme Market Share by Type (2019-2030)
 Figure 29. Europe mRNA Raw Enzyme Market Share by Application (2019-2030)
 Figure 30. Europe mRNA Raw Enzyme Market Share by Country (2019-2030)
 Figure 31. Germany mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. France mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. U.K. mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Italy mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Russia mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Nordic Countries mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. China mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. China mRNA Raw Enzyme Market Share by Type (2019-2030)
 Figure 39. China mRNA Raw Enzyme Market Share by Application (2019-2030)
 Figure 40. Asia mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Asia mRNA Raw Enzyme Market Share by Type (2019-2030)
 Figure 42. Asia mRNA Raw Enzyme Market Share by Application (2019-2030)
 Figure 43. Asia mRNA Raw Enzyme Market Share by Region (2019-2030)
 Figure 44. Japan mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. South Korea mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. China Taiwan mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Southeast Asia mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. India mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Australia mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Share by Type (2019-2030)
 Figure 52. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Share by Application (2019-2030)
 Figure 53. Middle East, Africa, and Latin America mRNA Raw Enzyme Market Share by Country (2019-2030)
 Figure 54. Brazil mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Mexico mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Turkey mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 57. Saudi Arabia mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 58. Israel mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 59. GCC Countries mRNA Raw Enzyme Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 60. Thermo Fisher Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 61. NEB Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 62. TriLink Bio Technologies Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 63. Merck Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 64. Aldevron Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 65. Qiagen N.V. Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 66. Promega Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 67. Roche CustomBiotech Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 68. Takara Bio Inc Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 69. Novoprotein Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 70. Vazyme Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 71. Hongene Biotech Corporatio Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 72. Yeasen Biotechnology (Shanghai) Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 73. Kactus Biosystems Revenue Growth Rate in mRNA Raw Enzyme Business (2019-2024)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed